Immune System Disorders
Disease State Hub
Featured
12/18/2024
Miranda Manier, BA
In a phase 3 trial, inebilizumab, a monoclonal antibody targeting CD19+ B cells, reduced flare rates and improved treatment-free and glucocorticoid-free remission in patients with immunoglobulin G4-related...
12/18/2024
10/16/2024
Miranda Manier, BA
A recent study found that carrimycin significantly improved immune function and reduced disease severity in patients with tumors who have sepsis, highlighting its potential as an effective immune-modulating...
10/16/2024
06/29/2023
Infants are defined as “children aged 1 month to 1 year.” How many vaccinations are recommended for the average infant in the United States? Take our pop quiz to test your knowledge!
06/29/2023
Interactive Features
06/29/2023
Infants are defined as “children aged 1 month to 1 year.” How many vaccinations are recommended for the average infant in the United States? Take our pop quiz to test your knowledge!
06/29/2023
12/09/2021
Immunotherapy is underused in patients with asthma, partly because of concerns about cost and partly because of limited efficacy data.
12/09/2021
11/22/2015
Researchers recently investigated inebilizumab as a potential treatment option for patients with immunoglobulin G4-related disease. Test your understanding of the findings!
11/22/2015
Clinical Insights
10/14/2021
He talks about HIV resistance in the context of pre-exposure prophylaxis use, how common it is, and how PrEP might influence subsequent therapies.
10/14/2021
04/16/2019
Deepak Kaushal, PhD, from Texas Biomedical Research Institute, talks about new treatments for HIV, how they will change the way we treat HIV, and other medications for HIV on the horizon.
04/16/2019
02/13/2019
In this podcast, she discusses her research on developing a vaccine for HIV-tuberculosis co-infection.
02/13/2019
12/09/2018
Shane Crotty, PhD, from the La Jolla Institute for Immunology, talks about his discovery of the Tfh pathway and how it has affected the development of vaccines.
12/09/2018
06/08/2017
Michael Banks, MD, discusses the new genomic test created to determine a patient's tumor mutation burden, which could help identify patients that would benefit from...
06/08/2017
